Rannio, T <br/><br/>
Three out of four disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort.  [electronic resource] 

 -  Scandinavian journal of rheumatology  Nov 2017 
 - 425-431 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1502-7732 
<br/><br/><label>Standard No.: </label>10.1080/03009742.2016.1266029  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Rheumatoid--drug therapy<br/>Biological Products--therapeutic use<br/>Cohort Studies<br/>Drug Therapy, Combination<br/>Female<br/>Finland<br/>Glucocorticoids--therapeutic use<br/>Humans<br/>Hydroxychloroquine--therapeutic use<br/>Logistic Models<br/>Male<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Multivariate Analysis<br/>Patient Reported Outcome Measures<br/>Remission Induction<br/>Severity of Illness Index<br/>Sulfasalazine--therapeutic use<br/>Treatment Outcome